Annual report pursuant to Section 13 and 15(d)

Income Taxes (Details 2)

v3.5.0.2
Income Taxes (Details 2) - USD ($)
$ in Thousands
Jun. 30, 2016
Jun. 30, 2015
Deferred tax assets (liabilities):    
Net operating loss $ 17,172 $ 14,213
Share-based compensation 726 3,992
Research and development tax credits 1,097 890
Suspended losses in iBio CMO 255 0
Basis in iBio CMO 145 0
Intangible assets (219) (188)
Vacation accrual and other 17 16
Valuation allowance (19,193) (18,923)
Total $ 0 $ 0